Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GPCR |
---|---|---|
09:32 ET | 4968 | 45.03 |
09:34 ET | 2500 | 45.56 |
09:36 ET | 700 | 45.36 |
09:38 ET | 100 | 45.55 |
09:39 ET | 1800 | 45.6 |
09:41 ET | 1900 | 45.41 |
09:43 ET | 3150 | 45.28 |
09:45 ET | 7764 | 45.365 |
09:48 ET | 4878 | 44.86 |
09:50 ET | 400 | 44.8 |
09:52 ET | 1500 | 44.75 |
09:54 ET | 16548 | 44.02 |
09:56 ET | 4986 | 44.17 |
09:57 ET | 3400 | 44.26 |
09:59 ET | 920 | 44.4 |
10:01 ET | 4297 | 44.475 |
10:03 ET | 5000 | 44.535 |
10:06 ET | 5690 | 44.51 |
10:08 ET | 13570 | 44.38 |
10:10 ET | 1925 | 44.37 |
10:12 ET | 21047 | 44.235 |
10:14 ET | 5350 | 44.25 |
10:15 ET | 700 | 44.215 |
10:17 ET | 6046 | 44.5 |
10:19 ET | 790 | 44.48 |
10:21 ET | 13492 | 44.215 |
10:24 ET | 4316 | 44.34 |
10:26 ET | 500 | 44.33 |
10:28 ET | 3018 | 44.325 |
10:30 ET | 26650 | 44 |
10:32 ET | 3469 | 44.015 |
10:33 ET | 13671 | 43.73 |
10:35 ET | 3630 | 44.02 |
10:37 ET | 5902 | 44.165 |
10:39 ET | 300 | 43.99 |
10:42 ET | 1200 | 44.02 |
10:44 ET | 3396 | 44 |
10:46 ET | 2305 | 44 |
10:48 ET | 1790 | 43.9181 |
10:50 ET | 1700 | 43.77 |
10:51 ET | 5324 | 43.9 |
10:53 ET | 5529 | 43.89 |
10:55 ET | 6662 | 44 |
10:57 ET | 1435 | 44.04 |
11:00 ET | 300 | 44.05 |
11:02 ET | 600 | 44.03 |
11:04 ET | 3499 | 43.94 |
11:06 ET | 2100 | 43.92 |
11:08 ET | 1400 | 43.935 |
11:09 ET | 3495 | 44.06 |
11:11 ET | 1700 | 44.19 |
11:13 ET | 144785 | 44.17 |
11:15 ET | 8600 | 44.09 |
11:18 ET | 18682 | 43.98 |
11:20 ET | 4705 | 43.95 |
11:22 ET | 8700 | 44.18 |
11:24 ET | 5460 | 44.36 |
11:26 ET | 1500 | 44.335 |
11:27 ET | 4827 | 44.54 |
11:29 ET | 3500 | 44.61 |
11:31 ET | 500 | 44.57 |
11:33 ET | 2982 | 44.64 |
11:36 ET | 1300 | 44.725 |
11:38 ET | 16696 | 44.655 |
11:40 ET | 13763 | 44.42 |
11:42 ET | 4835 | 44.215 |
11:44 ET | 5840 | 44.195 |
11:47 ET | 400 | 44.125 |
11:49 ET | 300 | 44.2 |
11:51 ET | 500 | 44.07 |
11:54 ET | 899 | 44.08 |
11:56 ET | 2660 | 44.05 |
11:58 ET | 10040 | 43.52 |
12:00 ET | 8908 | 43.75 |
12:02 ET | 2024 | 43.68 |
12:03 ET | 1914 | 43.71 |
12:05 ET | 1960 | 43.73 |
12:07 ET | 1100 | 43.75 |
12:09 ET | 10687 | 43.91 |
12:12 ET | 2500 | 43.99 |
12:14 ET | 1638 | 44.08 |
12:16 ET | 2525 | 43.975 |
12:18 ET | 400 | 43.93 |
12:20 ET | 5730 | 44.15 |
12:21 ET | 5589 | 44.07 |
12:23 ET | 500 | 44.135 |
12:25 ET | 52204 | 44.15 |
12:27 ET | 100 | 44.325 |
12:30 ET | 400 | 44.4 |
12:32 ET | 200 | 44.39 |
12:34 ET | 625 | 44.375 |
12:36 ET | 100 | 44.31 |
12:38 ET | 500 | 44.365 |
12:39 ET | 2630 | 44.54 |
12:41 ET | 515 | 44.6227 |
12:43 ET | 1449 | 44.4773 |
12:45 ET | 1369 | 44.11 |
12:48 ET | 400 | 44.14 |
12:50 ET | 8748 | 44.33 |
12:52 ET | 5472 | 44.675 |
12:54 ET | 2500 | 44.73 |
12:56 ET | 980 | 44.71 |
12:57 ET | 800 | 44.64 |
12:59 ET | 1373 | 44.66 |
01:01 ET | 117 | 44.67 |
01:03 ET | 9654 | 45.005 |
01:06 ET | 700 | 45 |
01:08 ET | 2720 | 44.97 |
01:10 ET | 1619 | 45.02 |
01:12 ET | 4384 | 45.215 |
01:14 ET | 500 | 45.19 |
01:15 ET | 100 | 45.04 |
01:17 ET | 2550 | 44.91 |
01:19 ET | 454 | 44.98 |
01:21 ET | 3600 | 44.91 |
01:24 ET | 700 | 44.895 |
01:26 ET | 200 | 44.9 |
01:28 ET | 400 | 44.77 |
01:30 ET | 700 | 44.73 |
01:32 ET | 6151 | 45.31 |
01:33 ET | 800 | 45.24 |
01:35 ET | 500 | 45.185 |
01:37 ET | 1205 | 45.16 |
01:39 ET | 2497 | 45.27 |
01:42 ET | 2733 | 45.31 |
01:44 ET | 1252 | 45.345 |
01:46 ET | 12666 | 45.065 |
01:48 ET | 3197 | 44.9 |
01:50 ET | 2208 | 44.75 |
01:51 ET | 801 | 44.63 |
01:53 ET | 3262 | 44.71 |
01:55 ET | 4850 | 44.67 |
01:57 ET | 3250 | 44.76 |
02:00 ET | 650 | 44.625 |
02:02 ET | 700 | 44.505 |
02:04 ET | 1210 | 44.465 |
02:06 ET | 1489 | 44.3 |
02:08 ET | 3800 | 44.42 |
02:09 ET | 753 | 44.43 |
02:11 ET | 685 | 44.43 |
02:13 ET | 2677 | 44.57 |
02:15 ET | 2850 | 44.3575 |
02:18 ET | 1178 | 44.38 |
02:20 ET | 400 | 44.3201 |
02:22 ET | 300 | 44.3 |
02:24 ET | 1225 | 44.285 |
02:26 ET | 8205 | 44.105 |
02:27 ET | 4800 | 44.16 |
02:29 ET | 13514 | 44.135 |
02:31 ET | 7125 | 44 |
02:33 ET | 1980 | 43.83 |
02:36 ET | 4026 | 44.08 |
02:38 ET | 1442 | 43.995 |
02:40 ET | 1300 | 43.96 |
02:42 ET | 18181 | 43.89 |
02:44 ET | 329 | 43.89 |
02:45 ET | 4673 | 44.1 |
02:47 ET | 802 | 44.06 |
02:49 ET | 6216 | 44.07 |
02:51 ET | 2100 | 44 |
02:54 ET | 6476 | 43.945 |
02:56 ET | 1770 | 43.9 |
02:58 ET | 2100 | 43.76 |
03:00 ET | 7464 | 43.97 |
03:02 ET | 1930 | 43.98 |
03:03 ET | 8343 | 44.05 |
03:05 ET | 6257 | 44.01 |
03:07 ET | 28240 | 44.17 |
03:12 ET | 900 | 44.065 |
03:14 ET | 2567 | 44.13 |
03:16 ET | 13619 | 44.28 |
03:18 ET | 1081 | 44.2094 |
03:20 ET | 3444 | 44.15 |
03:21 ET | 5913 | 44.335 |
03:23 ET | 2181 | 44.18 |
03:25 ET | 27143 | 44.135 |
03:27 ET | 2952 | 44.03 |
03:30 ET | 1652 | 44.2 |
03:32 ET | 1614 | 44.08 |
03:34 ET | 4467 | 44.14 |
03:36 ET | 4207 | 43.76 |
03:38 ET | 6421 | 43.9 |
03:39 ET | 2746 | 43.77 |
03:41 ET | 9590 | 43.74 |
03:43 ET | 7545 | 43.22 |
03:45 ET | 10402 | 43.14 |
03:48 ET | 13717 | 43.04 |
03:50 ET | 24887 | 43.5 |
03:52 ET | 13205 | 43.78 |
03:54 ET | 18299 | 43.815 |
03:56 ET | 14170 | 43.54 |
03:57 ET | 40842 | 43.52 |
03:59 ET | 55806 | 43.68 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Structure Therapeutics Inc | 2.6B | -18.8x | --- |
SpringWorks Therapeutics Inc | 2.7B | -7.0x | --- |
MoonLake Immunotherapeutics | 2.5B | -51.6x | --- |
Geron Corp | 2.8B | -13.3x | --- |
Agios Pharmaceuticals Inc | 2.6B | -7.2x | --- |
Xenon Pharmaceuticals Inc | 2.8B | -13.8x | --- |
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.32 |
Book Value | $9.76 |
P/E Ratio | -18.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.